Table 3.

Co-expressions of OCT4, SOX2, and NANOG in BC tissues

Parameters	HER2+ BC patients (N=134)
Patients with no positive marker, n (%)	76 (56.7)
Patients with at least one positive marker, n (%)	58 (43.3)
Patients with two positive markers, n (%)
OCT4 positive and SOX2 positive	17 (12.7)
OCT4 positive and NANOG positive	23 (17.2)
SOX2 positive and NANOG positive	17 (12.7)
Patients with at least two positive markers, n (%)	31 (23.1)
Patients with all three positive markers, n (%)	13 (9.7)

Note: Data are presented as counts (percentage).

Abbreviations: BC, breast cancer; HER2, human epidermal growth factor receptor 2.